Dimensional Fund Advisors LP Has $96.42 Million Position in Veeva Systems Inc. $VEEV

Dimensional Fund Advisors LP boosted its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 6.3% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 548,859 shares of the technology company’s stock after acquiring an additional 32,319 shares during the period. Dimensional Fund Advisors LP’s holdings in Veeva Systems were worth $96,421,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the business. SHP Wealth Management acquired a new stake in shares of Veeva Systems in the 4th quarter worth about $26,000. Newbridge Financial Services Group Inc. raised its stake in shares of Veeva Systems by 322.6% in the fourth quarter. Newbridge Financial Services Group Inc. now owns 131 shares of the technology company’s stock worth $29,000 after purchasing an additional 100 shares during the last quarter. Activest Wealth Management lifted its holdings in shares of Veeva Systems by 3,175.0% in the fourth quarter. Activest Wealth Management now owns 131 shares of the technology company’s stock valued at $29,000 after purchasing an additional 127 shares in the last quarter. MV Capital Management Inc. purchased a new position in shares of Veeva Systems during the fourth quarter valued at approximately $30,000. Finally, Reflection Asset Management bought a new stake in Veeva Systems during the fourth quarter worth $32,000. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Piper Sandler cut their price target on shares of Veeva Systems from $285.00 to $235.00 and set an “overweight” rating on the stock in a report on Thursday, June 4th. The Goldman Sachs Group decreased their price objective on shares of Veeva Systems from $190.00 to $165.00 and set a “sell” rating for the company in a report on Thursday, June 4th. Mizuho lowered their price target on shares of Veeva Systems from $295.00 to $270.00 and set an “outperform” rating on the stock in a report on Thursday, June 4th. BTIG Research reissued a “buy” rating and set a $340.00 price objective on shares of Veeva Systems in a report on Thursday, June 4th. Finally, Weiss Ratings upgraded Veeva Systems from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Friday, July 10th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $247.08.

Veeva Systems Price Performance

Shares of Veeva Systems stock opened at $207.82 on Thursday. Veeva Systems Inc. has a 1 year low of $148.05 and a 1 year high of $310.50. The firm has a market cap of $33.76 billion, a PE ratio of 37.04, a PEG ratio of 0.87 and a beta of 0.94. The company has a 50 day simple moving average of $176.81 and a two-hundred day simple moving average of $180.51.

Veeva Systems (NYSE:VEEV) last posted its quarterly earnings data on Wednesday, June 3rd. The technology company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. Veeva Systems had a net margin of 28.37% and a return on equity of 13.72%. The firm had revenue of $882.95 million for the quarter, compared to analysts’ expectations of $857.73 million. During the same quarter last year, the company posted $1.97 EPS. The business’s quarterly revenue was up 16.3% on a year-over-year basis. Veeva Systems has set its FY 2027 guidance at 9.050-9.050 EPS and its Q2 2027 guidance at 2.210-2.220 EPS. As a group, research analysts anticipate that Veeva Systems Inc. will post 6.65 earnings per share for the current year.

Veeva Systems Company Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.